Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FL070
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $56,339
Award facts
- Contract value 100% obligated
- $56,338.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $56,338.53 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 29, 2026, with completion scheduled for January 30, 2026. The order is for RINVOQ ER 15 mg tablets in quantities of 30s, a JAK inhibitor used to treat inflammatory conditions. This is a non-set-aside award issued under competitive procedures, with performance at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a child entity under parent company Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor specializing in providing medical products and healthcare solutions to federal agencies.
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products, medical supplies, specialty medications, brand-name and generic drugs, vaccines, and related medical commodities to support military healthcare programs worldwide. The contract supports critical federal healthcare needs including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, demonstrating AmerisourceBergen's significant role in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FL070?
SPE2DR26FL070 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FL070 worth?
The government has obligated $56,339 on SPE2DR26FL070.
Is contract SPE2DR26FL070 an order under another contract?
Yes. SPE2DR26FL070 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FL070 competed?
The extent of competition for SPE2DR26FL070 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award